NCT03683433
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Acute Biphenotypic Leukemia
Explore clinical trials studying Acute Biphenotypic Leukemia. Study availability and eligibility vary by location and protocol.
26 public trials
5 recruiting studies
Acute Biphenotypic Leukemia trial results
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02115295
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
NCT04797767
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07819396
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +52 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Not yet recruiting
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
NCT07710781
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
- Locations
-
Not specified
Active, not recruiting
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting
NCT04128501
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT05589896
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
- Locations
-
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
- Henry Ford Cancer Institute Detroit, Michigan, United States
Active, not recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Dana Farber / Boston Children's Hospital Boston, Massachusetts, United States